Antioxidant mechanisms of isoflavones in lipid systems: paradoxical effects of peroxyl radical scavenging.

[1]  A. Carr,et al.  Potential Antiatherogenic Mechanisms of Ascorbate (Vitamin C) and α-Tocopherol (Vitamin E) , 2000 .

[2]  T. Sanders,et al.  Isoflavone phytoestrogens consumed in soy decrease F(2)-isoprostane concentrations and increase resistance of low-density lipoprotein to oxidation in humans. , 2000, The American journal of clinical nutrition.

[3]  M. Kikuchi,et al.  Isoflavone aglycone-rich extract without soy protein attenuates atherosclerosis development in cholesterol-fed rabbits. , 2000, The Journal of nutrition.

[4]  F. Ursini,et al.  Synergistic inhibition of LDL oxidation by phytoestrogens and ascorbic acid. , 2000, Free radical biology & medicine.

[5]  H. Adlercreutz,et al.  Dietary soy-derived isoflavone phytoestrogens. Could they have a role in coronary heart disease prevention? , 2000, Biochemical pharmacology.

[6]  D. Liebler,et al.  Reactions of Genistein with alkylperoxyl radicals. , 2000, Chemical research in toxicology.

[7]  H. Jo,et al.  Cell signaling by reactive nitrogen and oxygen species in atherosclerosis. , 2000, Free radical biology & medicine.

[8]  A. Kettle,et al.  Comparison of mono- and dichlorinated tyrosines with carbonyls for detection of hypochlorous acid modified proteins. , 2000, Archives of biochemistry and biophysics.

[9]  D. Giugliano.  Dietary antioxidants for cardiovascular prevention. , 2000, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[10]  A. Carr,et al.  Potential antiatherogenic mechanisms of ascorbate (vitamin C) and alpha-tocopherol (vitamin E). , 2000, Circulation research.

[11]  I. Puddey,et al.  Alcohol, Stroke and Coronary Heart Disease , 1999, Neuroepidemiology.

[12]  S. Barnes,et al.  Chlorination and nitration of soy isoflavones. , 1999, Archives of biochemistry and biophysics.

[13]  K. Williams,et al.  Atherosclerosis--an inflammatory disease. , 1999, The New England journal of medicine.

[14]  Andrew C. Terentis,et al.  Tocopherol‐mediated peroxidation of lipoproteins: implications for vitamin E as a potential antiatherogenic supplement , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[15]  V. Darley-Usmar,et al.  Molecular mechanisms of the copper dependent oxidation of low-density lipoprotein. , 1999, Free radical research.

[16]  U. Urzúa,et al.  Plasma polyphenols and antioxidants, oxidative DNA damage and endothelial function in a diet and wine intervention study in humans. , 1999, Drugs under experimental and clinical research.

[17]  I. Puddey,et al.  Alcohol, stroke and coronary heart disease. Are there anti-oxidants and pro-oxidants in alcoholic beverages that might influence the development of atherosclerotic cardiovascular disease? , 1999, Neuroepidemiology.

[18]  M. Anthony,et al.  Effects of soy isoflavones on atherosclerosis: potential mechanisms. , 1998, The American journal of clinical nutrition.

[19]  N. Kerry,et al.  The isoflavone genistein inhibits copper and peroxyl radical mediated low density lipoprotein oxidation in vitro. , 1998, Atherosclerosis.

[20]  S. Parthasarathy,et al.  Oxidized low-density lipoprotein, a two-faced Janus in coronary artery disease? , 1998, Biochemical pharmacology.

[21]  A. Chait,et al.  Dietary isoflavones reduce plasma cholesterol and atherosclerosis in C57BL/6 mice but not LDL receptor-deficient mice. , 1998, The Journal of nutrition.

[22]  S. Ojala,et al.  Effect of soybean phytoestrogen intake on low density lipoprotein oxidation resistance. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[23]  S. Barnes.  Evolution of the Health Benefits of Soy Isoflavones , 1998, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[24]  R. Coleman,et al.  Reduced progression of atherosclerosis in apolipoprotein E-deficient mice following consumption of red wine, or its polyphenols quercetin or catechin, is associated with reduced susceptibility of LDL to oxidation and aggregation. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[25]  J. D. Wagner,et al.  Soy protein versus soy phytoestrogens in the prevention of diet-induced coronary artery atherosclerosis of male cynomolgus monkeys. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[26]  C. Seelos,et al.  Genistein, the dietary-derived angiogenesis inhibitor, prevents LDL oxidation and protects endothelial cells from damage by atherogenic LDL. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[27]  M. Wilson,et al.  Reduction of Cu(II) by lipid hydroperoxides: implications for the copper-dependent oxidation of low-density lipoprotein. , 1997, The Biochemical journal.

[28]  C. Rice-Evans,et al.  Antioxidant activity of phytoestrogenic isoflavones. , 1997, Free radical research.

[29]  M. Wilson,et al.  Formation of oxysterols during oxidation of low density lipoprotein by peroxynitrite, myoglobin, and copper. , 1996, Journal of lipid research.

[30]  C. Cross,et al.  Formation of Nitrating and Chlorinating Species by Reaction of Nitrite with Hypochlorous Acid , 1996, The Journal of Biological Chemistry.

[31]  C. Rice-Evans,et al.  Structure-antioxidant activity relationships of flavonoids and phenolic acids. , 1996, Free radical biology & medicine.

[32]  V. Darley-Usmar,et al.  Using peroxynitrite as oxidant with low-density lipoprotein. , 1996, Methods in enzymology.

[33]  J. Berliner,et al.  The role of oxidized lipoproteins in atherogenesis. , 1996, Free radical biology & medicine.

[34]  B. Kalyanaraman,et al.  Role of apolipoprotein B-derived radical and alpha-tocopheroxyl radical in peroxidase-dependent oxidation of low density lipoprotein. , 1995, Journal of lipid research.

[35]  P. Edwards,et al.  Atherosclerosis: basic mechanisms. Oxidation, inflammation, and genetics. , 1995, Circulation.

[36]  M. Wilson,et al.  The role of lipid hydroperoxides in the myoglobin-dependent oxidation of LDL. , 1994, Archives of Biochemistry and Biophysics.

[37]  S. Parthasarathy,et al.  Mechanisms of oxidation, antioxidants, and atherosclerosis , 1994, Current opinion in lipidology.

[38]  I. Hirsch,et al.  Reduced Plasma Peroxyl Radical Trapping Capacity and Increased Susceptibility of LDL to Oxidation In Poorly Controlled IDDM , 1994, Diabetes.

[39]  D. R. Duling,et al.  Simulation of multiple isotropic spin-trap EPR spectra. , 1994, Journal of magnetic resonance. Series B.

[40]  H. Ischiropoulos,et al.  Oxidative chemistry of peroxynitrite. , 1994, Methods in enzymology.

[41]  G. Bellomo,et al.  Low-density lipoprotein oxidation in essential hypertension , 1993, Journal of hypertension.

[42]  S. Moncada,et al.  The oxidation of α‐tocopherol in human low‐density lipoprotein by the simultaneous generation of superoxide and nitric oxide , 1993 .

[43]  S. Moncada,et al.  Peroxynitrite and atherosclerosis. , 1993, Biochemical Society transactions.

[44]  M. Wilson,et al.  The oxidation of alpha-tocopherol in human low-density lipoprotein by the simultaneous generation of superoxide and nitric oxide. , 1993, FEBS letters.

[45]  R. Stocker,et al.  Vitamin E in human low-density lipoprotein. When and how this antioxidant becomes a pro-oxidant. , 1992, The Biochemical journal.

[46]  A. Hamsten,et al.  Susceptibility to low-density lipoprotein oxidation and coronary atherosclerosis in man , 1992, The Lancet.

[47]  S. Wolff,et al.  Ferrous ion oxidation in the presence of xylenol orange for detection of lipid hydroperoxide in low density lipoprotein. , 1992, Analytical biochemistry.

[48]  J. Joseph,et al.  Synergistic interaction between the probucol phenoxyl radical and ascorbic acid in inhibiting the oxidation of low density lipoprotein. , 1992, The Journal of biological chemistry.

[49]  V. Darley-Usmar,et al.  Pro-oxidant effects of lipoxygenase-derived peroxides on the copper-initiated oxidation of low-density lipoprotein. , 1992, The Biochemical journal.

[50]  M. Wilson,et al.  The simultaneous generation of superoxide and nitric oxide can initiate lipid peroxidation in human low density lipoprotein. , 1992, Free radical research communications.

[51]  S. Barnes,et al.  Genistein inhibition of the growth of human breast cancer cells: independence from estrogen receptors and the multi-drug resistance gene. , 1991, Biochemical and biophysical research communications.

[52]  H. Esterbauer,et al.  Effect of oral supplementation with D-alpha-tocopherol on the vitamin E content of human low density lipoproteins and resistance to oxidation. , 1991, Journal of lipid research.

[53]  H. Esterbauer,et al.  Effect of antioxidants on oxidative modification of LDL. , 1991, Annals of medicine.

[54]  J. Liehr,et al.  Characterization of semiquinone free radicals formed from stilbene catechol estrogens. An ESR spin stabilization and spin trapping study. , 1989, The Journal of biological chemistry.

[55]  A. Hersey,et al.  A method for the comparative assessment of antioxidants as peroxyl radical scavengers. , 1989, Biochemical pharmacology.

[56]  J L Witztum,et al.  Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. , 1989, The New England journal of medicine.

[57]  H. Esterbauer,et al.  Continuous monitoring of in vitro oxidation of human low density lipoprotein. , 1989, Free radical research communications.

[58]  J. Segrest,et al.  Preparative and quantitative isolation of plasma lipoproteins: rapid, single discontinuous density gradient ultracentrifugation in a vertical rotor. , 1980, Journal of lipid research.